# Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy

> **NCT04753749** · NA · COMPLETED · sponsor: **MicroPort CRM** · enrollment: 2248 (actual)

## Conditions studied

- Myocardial Infarction, Acute
- Coronary Artery Disease

## Interventions

- **DRUG:** Shortened DAPT followed by P2Y12 inhibitor monotherapy (cessation of aspirin)
- **DRUG:** Standard DAPT

## Key facts

- **NCT ID:** NCT04753749
- **Lead sponsor:** MicroPort CRM
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-25
- **Primary completion:** 2025-05-05
- **Final completion:** 2025-05-05
- **Target enrollment:** 2248 (ACTUAL)
- **Last updated:** 2025-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04753749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04753749, "Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04753749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*